Lipid Panel

CPT Code:  80061 
Test Includes: Total Cholesterol; High-Density Lipoprotein (HDL) Cholesterol; Low-Density Lipoprotein (LDL) Cholesterol (calculation); Triglycerides; Very Low-Density Lipoprotein (VLDL) Cholesterol (calculation) 
Specimen:    Serum or plasma 
Volume:  2 mL 
Minimum Volume:   0.5 mL
Container:  Gel-barrier transport, green-top (heparin) tube, or lavender-top (EDTA) tube 
Methodology:   See individual tests. 
Collection:  Separate serum or plasma from cells within 45 minutes of collection. Lipid panels are best avoided for three months following acute myocardial infarction, although cholesterol can be measured in the first 24 hours. 

Reference Range: 

Test  Range 
Total Cholesterol  100-199 mg/dL 
Triglycerides 0-149 mg/dL 
HDL Cholesterol Calc  >39 mg/dL 
LDL Cholesterol Calc. 0-99 mg/dL
VLDL Cholesterol Calc. 5-40 mg/dL
Total Cholesterol/HDL Ratio    0.0-5.0 ratio units
LDL/HDL Ratio 0.0-3.5 ratio units


Stability:   See Individual Tests 

Evaluate hyperlipidemia as an index to coronary artery disease. Investigation of serum lipids is indicated in those with coronary and other arterial disease, especially when it is premature, and in those with family history of atherosclerosis or of hyperlipidemia.

Lipid profiling may also lead to detection of some cases of hypothyroidism. Primary hyperlipoproteinemia includes hypercholesterolemia, a direct risk factor for coronary heart disease. Secondary hyperlipoproteinemia includes increases of lipoproteins secondary to hypothyroidism, nephrosis, renal failure, obesity, diabetes mellitus, alcoholism, primary biliary cirrhosis, and other types of cholestasis.

Decreased lipids are found with some cases of malabsorption, malnutrition, and advanced liver disease.

Causes for Rejection:    Hemolysis
Interfering Substances:  See Individual Tests